Company research / CGC

Canopy Growth Corp (CGC)

CIK 0001737927 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, Canopy Growth Corp reported revenue of 284.60M CAD. Revenue grew 5.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was 293.63M CAD.

Key ratios (year ended 2026-03-31)

24.5%
Gross margin
-56.8%
Operating margin
-92.4%
Net margin
-37.7%
Return on year-end equity
5.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-16

Headquarters locality: Smiths Falls · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-10, first reflected in a filing dated 2024-02-09. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31
Revenue293.63M CAD284.60M CADn/an/an/a269.00M CADn/an/an/a297.15M CADn/a
Cost of Revenue219.76M CAD214.93M CADn/an/an/a189.48M CADn/an/an/a216.26M CADn/a
Gross Profit73.87M CAD69.67M CADn/an/an/a79.51M CADn/an/an/a80.88M CADn/a
R&D Expensen/a2.61M CADn/an/an/a2.74M CADn/an/an/a4.61M CADn/a
Operating Income-161.15M CAD-161.66M CADn/an/an/a-117.14M CADn/an/an/a-228.71M CADn/a
Net Income-232.63M CAD-262.91M CADn/an/an/a-508.88M CADn/an/an/a-693.68M CADn/a
EPS (Diluted)n/a-0.88 CADn/an/an/a-4.73 CADn/an/an/a-9.27 CADn/a
Total Assets1.10B CAD1.12B CADn/an/an/a917.70M CADn/an/an/a1.30B CADn/a
Total Liabilities415.29M CAD421.14M CAD359.06M CAD349.14M CAD427.68M CAD439.13M CAD606.22M CAD768.03M CAD819.11M CAD899.76M CAD824.61M CAD
Long-Term Debt240.20M CAD233.36M CADn/an/an/a304.07M CADn/an/an/an/an/a
Shareholders' Equity688.63M CAD697.59M CAD747.13M CAD720.69M CAD477.00M CAD478.57M CAD558.00M CAD464.31M CAD467.12M CAD400.57M CAD535.14M CAD
Cash & Equivalents336.62M CAD364.68M CADn/an/an/a113.81M CADn/an/an/a170.30M CADn/a
Operating Cash Flow-78.48M CAD-63.81M CADn/an/an/a-165.75M CADn/an/an/a-281.95M CADn/a
Capital Expenditures4.76M CAD5.33M CADn/an/an/a10.81M CADn/an/an/a3.45M CADn/a
Free Cash Flow-83.24M CAD-69.14M CADn/an/an/a-176.56M CADn/an/an/a-285.40M CADn/a
Shares Outstanding423.02M422.07Mn/an/an/a183.87Mn/an/an/a91.12Mn/a
Weighted Average Diluted Sharesn/a298.04Mn/an/an/a107.55Mn/an/an/a74.79Mn/a
EPS (Basic)n/a-0.88 CADn/an/an/a-4.73 CADn/an/an/a-9.27 CADn/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView